Rosiglitazone in the UK: down but not out.
Iheanacho
Ike
I
iiheanacho@bmjgroup.com
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D017277:Drug Approval; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D006113:United Kingdom
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone